908 Devices Inc. (MASS): Cash & Equivalents
$70.52M
As of 2025-12-31
$63.02M
As of 2026-06-30
-27.9%
3-year compound annual growth
-15.0%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $70.52M | +60.1% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $44.03M | -63.6% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $121.04M | -35.8% | 2025-03-07, Balance as of period end |
| 2022-12-31 | $188.42M | -15.9% | 2024-03-08, Balance as of period end |
| 2021-12-31 | $224.07M | +40.7% | 2023-03-15, Balance as of period end |
| 2020-12-31 | $159.23M | n/a | 2022-03-11, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| 908 Devices Inc. (MASS) | 2025-12-31 | $70.52M | +60.1% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $8.61M | +109.7% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $20.03M | +18.4% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $101.82M | +2.1% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $2.99M | -67.4% |
| Precipio, Inc. (PRPO) | 2025-12-31 | $2.65M | +90.9% |
| Quanterix Corp (QTRX) | 2025-12-31 | $29.84M | -47.4% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $63.71M | +15.1% |
| Seer, Inc. (SEER) | 2025-12-31 | $47.28M | +16.0% |
Compare MASS, HBIO, RPID, EYPT side by side · Screen every company in Laboratory Analytical Instruments ↗